Literature DB >> 16937436

Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis.

Jian-Xian Yu1, Lin Cui, Qi-Yi Zhang, Hua Chen, Ping Ji, Hong-Jun Wei, Hai-Yan Ma.   

Abstract

AIM: To study CD34, CD105, inducible nitric oxide synthase (iNOS), endogenous nitric oxide synthase (eNOS), and hypoxia-inducible factor 1 (HIF-1) alpha expression in human colorectal carcinomas.
METHODS: The tissue microarrays (TMAs) were made up of 80 cases of colorectal carcinoma and 80 cases of non-neoplasm colorectal mucosa. The expression of CD34, CD105, NOS and HIF-1alpha was detected by immunohistochemistry (S-P).
RESULTS: iNOS and HIF-1alpha expression in colorectal carcinoma was significantly higher than in non-neoplasm colorectal mucosa (c2 = 43.166, P < 0.01; c2 = 10.4278, P < 0.01); eNOS expression in colorectal carcinoma was significantly lower than in non-neoplasm colorectal mucosa (c2 = 11.354, P < 0.01). The expression of iNOS correlated with differentiation (c2 = 18.141, P < 0.01), invasive depth (c2 = 4.748, P < 0.01), and Micro vessel density (MVD) (t = 2.327, P < 0.05). The expression of HIF-1alpha was correlated with infiltrating depth (c2 = 4.397, P < 0.05), Dukeos staging (c2 = 4.255, P < 0.05), and MVD (t = 2.272, P < 0.05). No correlation was found in eNOS expression.
CONCLUSION: Over-expression of iNOS and HIF-1alpha in colorectal carcinoma is correlated with the biological character MVD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937436      PMCID: PMC4087830          DOI: 10.3748/wjg.v12.i29.4660

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  More about: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.

Authors:  S B Fox; K C Gatter; R D Leek; A L Harris; K L Chew; B H Mayall; D H Moore
Journal:  J Natl Cancer Inst       Date:  2000-01-19       Impact factor: 13.506

Review 2.  Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.

Authors:  L Bubendorf; A Nocito; H Moch; G Sauter
Journal:  J Pathol       Date:  2001-09       Impact factor: 7.996

3.  Tumor hypoxia and gene expression--implications for malignant progression and therapy.

Authors:  R M Sutherland
Journal:  Acta Oncol       Date:  1998       Impact factor: 4.089

4.  Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers.

Authors:  S A Stacker; K Stenvers; C Caesar; A Vitali; T Domagala; E Nice; S Roufail; R J Simpson; R Moritz; T Karpanen; K Alitalo; M G Achen
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

5.  Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma.

Authors:  D Gancberg; A Di Leo; G Rouas; T Järvinen; A Verhest; J Isola; M J Piccart; D Larsimont
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

6.  Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells.

Authors:  J Dulak; A Józkowicz; A Dembinska-Kiec; I Guevara; A Zdzienicka; D Zmudzinska-Grochot; I Florek; A Wójtowicz; A Szuba; J P Cooke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

Review 7.  HIF-1 and tumor progression: pathophysiology and therapeutics.

Authors:  Gregg L Semenza
Journal:  Trends Mol Med       Date:  2002       Impact factor: 11.951

Review 8.  Angiogenesis inhibition in solid tumors.

Authors:  L S Rosen
Journal:  Cancer J       Date:  2001 Nov-Dec       Impact factor: 3.360

9.  Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity.

Authors:  Ronald Schimming; Dieter Marmé
Journal:  Head Neck       Date:  2002-02       Impact factor: 3.147

10.  Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Authors:  J Kononen; L Bubendorf; A Kallioniemi; M Bärlund; P Schraml; S Leighton; J Torhorst; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

View more
  12 in total

1.  Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.

Authors:  Sharon A Glynn; Brenda J Boersma; Tiffany H Dorsey; Ming Yi; Harris G Yfantis; Lisa A Ridnour; Damali N Martin; Christopher H Switzer; Robert S Hudson; David A Wink; Dong H Lee; Robert M Stephens; Stefan Ambs
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

2.  The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population.

Authors:  Soykan Arıkan; Canan Cacina; Erkan Guler; Serdar Çulcu; Gulay Tuna; Ilhan Yaylım-Eraltan
Journal:  Mol Biol Rep       Date:  2011-06-25       Impact factor: 2.316

3.  Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer.

Authors:  Torben Frøstrup Hansen; Flemming Brandt Sørensen; Karen-Lise Garm Spindler; Dorte Aalund Olsen; Rikke Fredslund Andersen; Jan Lindebjerg; Ivan Brandslund; Anders Jakobsen
Journal:  Virchows Arch       Date:  2010-02-09       Impact factor: 4.064

Review 4.  Inflammatory pathways in the early steps of colorectal cancer development.

Authors:  Francesco Mariani; Paola Sena; Luca Roncucci
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.

Authors:  Marleen van Oosten; Lucia Ma Crane; Joost Bart; Fijs W van Leeuwen; Gooitzen M van Dam
Journal:  Transl Oncol       Date:  2011-04-01       Impact factor: 4.243

6.  Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells.

Authors:  Zhenyu Ding; Li Yang; Xiaodong Xie; Fangwei Xie; Feng Pan; Jianjun Li; Jianming He; Houjie Liang
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

Review 7.  The chemical biology of nitric oxide: implications in cellular signaling.

Authors:  Douglas D Thomas; Lisa A Ridnour; Jeffrey S Isenberg; Wilmarie Flores-Santana; Christopher H Switzer; Sonia Donzelli; Perwez Hussain; Cecilia Vecoli; Nazareno Paolocci; Stefan Ambs; Carol A Colton; Curtis C Harris; David D Roberts; David A Wink
Journal:  Free Radic Biol Med       Date:  2008-04-04       Impact factor: 7.376

8.  Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice.

Authors:  Xiao-Bing Cui; Xia Guo; Shi-You Chen
Journal:  Cardiovasc Res       Date:  2013-05-21       Impact factor: 10.787

9.  An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer.

Authors:  Chih-Ching Yeh; Regina M Santella; Ling-Ling Hsieh; Fung-Chang Sung; Reiping Tang
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

10.  Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression.

Authors:  Nektaria Simiantonaki; Marios Taxeidis; Caren Jayasinghe; Ursula Kurzik-Dumke; Charles James Kirkpatrick
Journal:  BMC Cancer       Date:  2008-11-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.